Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.98% vs -35.66% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 112.45% vs -206.64% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 401.45% vs -93.14% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -25.17% vs -3.29% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Emergent BioSolutions, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.98% vs -35.66% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -29.75% vs -26.03% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 112.45% vs -206.64% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -90.00% vs 655.56% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 401.45% vs -93.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -53.62% vs 8.75% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -25.17% vs -3.29% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -25.17% vs -39.51% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






